LP
COGT icon

LMR Partners’s Cogent Biosciences COGT Stock Holding History

LMR Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Buy
55,389
+956
+2% +$35.3K ﹤0.01% 842
2025
Q4 		$1.93M Buy
+54,433
New +$1.53M ﹤0.01% 823
2024
Q4 		– Sell
-44,483
Closed -$480K – 1269
2024
Q3 		$480K Buy
+44,483
New +$433K ﹤0.01% 841
2021
Q2 		– Sell
-35,009
Closed -$307K – 1155
2021
Q1 		$307K Buy
+35,009
New +$337K 0.01% 727

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

LMR Partners's COGT Position: Q1 2026 in Review

LMR Partners increased its Cogent Biosciences (COGT) stake by 1.8% in Q1 2026, buying an estimated $35.3K and bringing the position to 55,389 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #842.

LMR Partners first reported a position in COGT in Q1 2021 and has held it in 4 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • LMR Partners held 55,389 shares of Cogent Biosciences worth $2.13M as of Q1 2026.
  • LMR Partners bought 956 Cogent Biosciences shares in Q1 2026, an estimated $35.3K.
  • Cogent Biosciences made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #842 holding.
  • LMR Partners first reported a position in Cogent Biosciences in Q1 2021 and has held it in 4 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.